Derek Hainy

Derek Hainy

Healthcare Regulation Expert
Derek Hainy is a public policy expert specializing in healthcare regulation. He provides insightful analysis of the latest regulatory changes affecting healthcare providers. Focusing on compliance, Derek helps medical professionals navigate healthcare laws, requirements, and reforms. He also covers the future of healthcare data privacy regulations and the regulatory landscape for telehealth services. 
Global Medical Radiation Shielding Market Analysis and Trends
Public Policy Global Medical Radiation Shielding Market Analysis and Trends

The quiet humming of a linear accelerator or the rapid click of a high-speed computed tomography scanner represents the pinnacle of modern diagnostic and therapeutic precision, yet these lifesaving technologies would be entirely unusable without the sophisticated engineering of the medical

Can States Protect Your Right to No-Cost Birth Control?
Public Policy Can States Protect Your Right to No-Cost Birth Control?

The legal architecture of American reproductive healthcare is currently facing a transformative period as the promise of universal, no-cost contraception encounters significant regulatory and judicial pushback. Since the implementation of the Affordable Care Act, the mandate for preventative

How Is Telemedicine Shaping the European Medical Cannabis Market?
Public Policy How Is Telemedicine Shaping the European Medical Cannabis Market?

The rapid expansion of specialized digital health platforms has fundamentally altered how patients interact with the medical cannabis market across the European continent through the use of integrated technological solutions. Digital prescription platforms and cross-border physician networks now

Texas AG Expands Gender Transition Ban to Mental Health Care
Public Policy Texas AG Expands Gender Transition Ban to Mental Health Care

The professional boundary between a therapist’s private consultation room and the state's executive chambers has dissolved as Texas transforms the landscape of pediatric behavioral health into a strictly regulated legal territory. While the initial wave of restrictions focused primarily on the

How Will Malta’s New Living Will Law Protect Patient Dignity?
Public Policy How Will Malta’s New Living Will Law Protect Patient Dignity?

The struggle between modern medical capabilities and the fundamental human right to a dignified natural death has reached a pivotal turning point in the Mediterranean. Malta is currently moving away from traditional medical paternalism toward a modern model centered on patient sovereignty and

How Will the New CRUSH Initiative Combat Healthcare Fraud?
Public Policy How Will the New CRUSH Initiative Combat Healthcare Fraud?

The federal government is fundamentally reshaping its approach to protecting taxpayer dollars by dismantling the traditional reactive mechanisms of the past while prioritizing immediate prevention. For decades, Medicare and Medicaid operated under a pay-and-chase philosophy that allowed billions to

Why Did the FDA Pause the Lorigerlimab LINNET Trial?
Public Policy Why Did the FDA Pause the Lorigerlimab LINNET Trial?

The landscape of gynecologic oncology treatment is undergoing a radical transformation as researchers attempt to bypass the limitations of traditional platinum-based chemotherapy through advanced molecular engineering. Modern oncology is currently defined by a move toward targeted therapies for

Top Healthcare Background Check Providers for 2026
Public Policy Top Healthcare Background Check Providers for 2026

The margin for error in clinical hiring has narrowed to a razor-thin line where a single oversight in a provider's history can result in catastrophic legal liabilities or the immediate revocation of federal funding. Modern healthcare systems no longer view background screening as a checkbox in

What Does Trump’s Healthcare Plan Mean for American Patients?
Public Policy What Does Trump’s Healthcare Plan Mean for American Patients?

Navigating the Shift from Public Safety Nets to Market-Driven Medicine The current shift in American healthcare policy marks a defining moment as the federal government moves away from the Affordable Care Act toward a more competitive, consumer-based framework. For several years, the national

FDA Shifts Regulatory Framework for Ultra-Rare Disease Therapies
Public Policy FDA Shifts Regulatory Framework for Ultra-Rare Disease Therapies

The traditional architecture of pharmaceutical development is undergoing a profound structural realignment as the Food and Drug Administration pivots toward a model that prioritizes molecular precision over the statistical breadth of massive clinical trials. This movement marks the definitive end

Loading
Latest Articles

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later